Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/cr0ph/staging.phastar.com/wp-includes/functions.php on line 6260
DSMBs and Interim Data Locks in Clinical Trials
Close-up of colourful medicine capsules with digital lighting

Interim Locks and DSMBs

3 minute read

Published: April 12th, 2017

Special consideration needs to be given to providing data for interim locks and DSMBs during the course of a study. It is crucial that the data provided for these milestones is as complete, accurate and up-to-date as possible because the outcome can have serious implications on the review and progress of the study. 

It is essential for data management to plan in advance the identification of key data, the level of cleaning required and agree timelines with the project team.  This strategic planning requires input and commitment from wider study team:

  • For electronic-data-capture studies, site personnel need to commit to entering the key data and responding to queries in a timely manner. For paper studies, CRFs must be completed and sent to the Data Entry department. Phastar work closely with the sponsor, clinical project managers and CRAs to provide assistance if required in database issues and ensure new user accounts are set up promptly.
  • Source document verification of key data must be completed in time for data management review and query resolution. 
  • Coding and approval of medical terms and medications must take place and time for queries must be considered.   Phastar Data Management code and query data on an ongoing basis to ensure there is no backlog.
  • Serious Adverse Event (SAE) reconciliation between the clinical database and the pharmacovigilance database, allowing time for queries to be resolved.  We build in regular timelines throughout a study for reconciliation of SAEs.
  • Cut-off dates for data need agreement from the whole study team and sponsor approval
  • If external data is required, then timelines must be agreed with the external vendors for data transmission to allow sufficient time for data reconciliation and query resolution
  • Data must be provided to the statistics department to allow sufficient time for programming activities. Phastar data management work together with the programming and stats team throughout a study, providing ongoing data transfers and regular meetings to discuss data issues.

Our data management staff have a great deal of experience in providing data for interim locks and DMCs. A Lead Data Manager is assigned to each study and that person will have detailed knowledge of the database and will be involved in project discussions and protocol deviation meetings. Data are reviewed on an ongoing basis immediately after data entry and source document verification, ensuring any issues are highlighted and addressed at an early stage. Interim locks should be performed on clean, QC’d data. Our databases allow locking of data at a CRF form level which enables the key data within a visit to be cleaned and locked whilst allowing ongoing processing of other data to continue.  Sometimes an interim analysis is requested on draft or dirty data.  However, there is a difference between dirty data and missing/incorrect data and we prioritise the interim data for early review to ensure the data is as accurate and complete as possible prior to use. The status of the data delivered for interim analysis is comprehensively documented.  

Related articles

Building a Successful Clinical Development Strategy with the Right Biometrics CRO 

Building a Successful Clinical Development Strategy with the Right Biometrics CRO 

November 9th, 2026 7 minute read

Clinical development teams are often familiar with outsourcing activities such as monitoring, project management, and...

Is the FSP Model Right for Your Clinical Program? 

Is the FSP Model Right for Your Clinical Program? 

November 6th, 2026 8 minute read

Clinical development teams are under constant pressure to deliver more with fixed budgets, tight timelines, and limit...

Meet the Team: Giles Partington, Consultant Statistician 

Meet the Team: Giles Partington, Consultant Statistician 

November 5th, 2026 4 minute read

In our “Meet the Team” series, we highlight the talented individuals who drive  Phastar’s success. Each t...